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Cyst growth in patients with autosomal dominant polycystic
kidney disease is thought to be due to increased tubular cell
proliferation. One model to explain this altered proliferation
suggests that the polycystin proteins PC1 and PC2 localize to
apical cilia and serve as an integral part of the flow-sensing
pathway thus modulating the proliferative response. We
measured proliferation and apoptosis in proximal tubule
derived cell lines lacking PC1. These cells showed increased
rates of proliferation, a decreased rate of apoptosis,
compared to control heterozygous cell lines, and
spontaneously formed cysts rather than tubules in an in vitro
tubulogenesis assay. Addition of neutrophil gelatinase
associated lipocalin (NGAL), a small secreted protein that
binds diverse ligands, to the cells lacking PC1 inhibited
proliferation and increased apoptosis leading to slower cyst
growth in vitro. Sustained over-expression at low level of
NGAL by an adenoviral delivery system suppressed cyst
enlargement without improving renal function in the Pkd1
mutant mice. Our studies show that renal epithelial cells
lacking PC1 have an inherent tendency to hyper-proliferate
forming cysts in vitro independent of a flow stimulus. The
potential benefit of attenuating cyst growth with NGAL
remains to be determined.
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Autosomal-dominant polycystic kidney disease is one of the
most common hereditary causes of kidney failure. The
disease occurs most often as a result of mutations in either
the PKD1 or PKD2 genes that encode the proteins polycystin-1
(PC1) and polycystin-2 (PC2), respectively.1,2 A prominent
feature of the disease is the development of cysts along multiple
segments of the nephron. Over a period of years, these cysts
enlarge and disrupt the normal kidney architecture, eventually
leading to end stage renal disease. The focal nature of the cysts
in humans with autosomal-dominant polycystic kidney disease
is thought to be because of the random acquisition of
mutations in the normal allele for the respective PKD gene in
some tubular cells.3–6 The subsequent cyst formation has been
proposed to require increased proliferation and/or decreased
differentiation of the mutant cells.1,2,7–9
Mouse models of PKD have been developed in which Pkd1
or Pkd2 have been mutated or knocked-out. Similar to
humans, mice that are heterozygous for the mutant Pkd1 or
Pkd2 gene exhibit normal kidney development and only
acquire cysts later in life.10,11 In contrast, homozygous loss of
either PC1 or PC2 expression results in extensive tubule
dilatation beginning at embryonic day 15.5 as well as
embryonic or perinatal lethality in the pups.11,12 The
observation that both PC1 and PC2 localize to primary cilia,
and that mutations in other cilial proteins can result in
phenotypic polycystic kidney disease in animal models,13–15
has recently led to a major focus on the role of aberrant cilia
function in the process of cyst formation. Evidence in
Madin–Darby canine kidney cells as well as other cell types
suggests that cilia are responsible for flow-dependent cellular
signaling.16 Consistent with this, cystic dilatation of the
tubules in Pkd1/ mice begins at approximately the same
time as glomerular filtration starts (BE15), leading some to
postulate that cilia act as flow sensors in vivo and that failure
of normal signaling by this sensor results in aberrant control
of tubular cell proliferation, apoptosis, and/or differentiation,
leading to progressive cyst formation.17
Polycystin genotype-dependent, but cilia-independent
phenotypes have also been reported. In vitro studies of renal
epithelial cells in which Pkd1 or Pkd2 have been over-
expressed, or cyst-lining cells obtained from kidneys of
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rodents with PKD, suggest that the level of polycystin
expression can influence the inherent tendency of epithelial
cells to form cysts in culture systems that lack a flow
component.18,19 Furthermore, PC1 has been localized to sites
of cell–cell as well as cell–matrix interaction,20,21 suggesting
that polycystins may be involved in signaling that is
independent of the primary cilium.
To study the role of PC1 in regulating cyst formation, we
have established Pkd1fl/ and Pkd1/ mouse proximal
tubule cell lines that are derived from a single common
parental Pkd1fl/ clone. As compared to Pkd1fl/ cells that
form tubular structures in a three-dimensional culture
system, Pkd1/ cells give rise primarily to cysts in vitro.
Furthermore, the null cells have increased rates of prolifera-
tion and decreased apoptosis resulting in more rapid
expansion of cell numbers.
On the basis of our previous observation that loss of
expression of the small secreted protein neutrophil gelati-
nase-associated lipocalin (NGAL) can induce cyst formation
in normal renal cell lines,22 we examined the effects of NGAL
on Pkd1/ cells. NGAL is a 24-kDa protein that is secreted
by multiple cells, including renal tubular cells, and whose
function remains incompletely understood. NGAL belongs to
a family of small secreted proteins that have been shown to
bind diverse ligands including bacterial siderophore, soluble
extracellular macromolecules, growth factors, and cell surface
receptors such as megalin.22–27 Multiple studies have
demonstrated that NGAL can act to either deliver those
factors or sequester them. For example, NGAL can bind
siderophore and thus sequester iron to inhibit bacterial
growth, as well as deliver iron intracellularly where it is
necessary for the regulation of iron-dependent enzymes.27 In
the present work, administration of exogenous NGAL was
found to increase apoptosis of Pkd1/ cells, resulting in
decreased cyst growth in vitro. In vivo expression of NGAL
using an adenoviral delivery system resulted in slowed
growth of cysts in a postnatal model of Pkd1-dependent cyst
formation, although blood urea nitrogen values were not
significantly improved by this treatment.
RESULTS
Pkd1/ cells preferentially form cysts in vitro
We have previously demonstrated that wild-type renal
tubular epithelial cells, when suspended in a 70:30 mixture
of collagen type I and Matrigel, predominantly form multi-
cellular tubular structures.28 To determine the influence of
Pkd1 gene expression on the tubulogenic potential of renal
epithelial cells, PN null cells and PH heterozygous control
cells were suspended in matrix as described in ‘Materials and
Methods’ and cultured in the absence of a flow stimulus.
Although PH cells formed elongated cord-shaped structures
(Figure 1a), cells lacking Pkd1 expression formed far greater
numbers of cystic structures (Figure 1b). Most cysts
developed a visible lumen whereas others grew as enlarging
spheres of cells. Quantitative analysis revealed that approxi-
mately 45% of structures formed by PN cells were cystic,
whereas PH cells almost exclusively formed branching linear
structures similar to those previously described for wild-type
proximal tubule and collecting duct cells (Figure 1c; Chen
et al.29 and Karihaloo et al.30).
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Figure 1 | Pkd1 null cells preferentially form cysts and hyperproliferate in vitro. Cells were suspended in a 70:30 collagen:Matrigel
mixture and grown for 5 days before quantitation of tubular or cystic structures. (a) Heterozygous PH cells formed mostly linear branching
structures with less than 3% cystic structures. (b) Pkd1 null PN cells formed a mixture of cystic structures (arrows) as well as structures that
were more linear in shape (arrowheads). (c) Quantitation of the percentage of cystic structures formed for each cell genotype; n¼ 8 for PN
(4 each for PN18 and PN24) and n¼ 6 for PH (3 each for PH2 and PH3) cells, respectively, *Po0.001. (d) A total of 1 104 cells from each
genotype were plated and cultured for 48 h in the presence of 10% FBS before trypsinization and counting; n¼ 4 for each cell type,
*Po0.005 vs the PH2 or PH3 cell lines. (e) Cells were cultured at equal densities and labeled with BrdU for 30 min. BrdU-positive cells were
detected by FACS analysis as described; n¼ 4 for each cell type, *Po0.002 vs the PH2 or PH3 cell lines. (f) Cells were cultured at equal
densities and serum starved for 48 h before harvest and Annexin V staining and FACS analysis as described; n¼ 3 separate experiments for
each cell line, *Po0.01 vs the PH2 or PH3 cell lines.
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Pkd1/ cells demonstrate increased proliferation and
decreased apoptosis compared to heterozygous cells
Cyst growth in polycystic kidney disease has been attributed,
among other causes, to an increased proliferative capacity of
cells lacking normal Pkd gene expression.19,31,32 In agreement
with this, Pkd1 null cells were found to require more frequent
passaging than heterozygous parental cells. When plated at
identical initial cell densities and grown for 4 days, Pkd1 null
cells demonstrated a significant increase in total cell number
as compared to PH or an independently isolated wild-type
proximal tubule cell line, MPT cells33,34 (Figure 1d).
The observed increase in total cell number could be due to
an increased rate of proliferation, a decreased rate of
apoptosis, or both. 5-Bromodeoxyuridine (BrdU) incorpora-
tion by subconfluent cells cultured in Dulbecco’s modified
Eagle’s medium (DMEM)/F12þ 2% fetal bovine serum (FBS)
revealed a significant increase in proliferation by Pkd1/ cells
as compared to PH cells (Figure 1e). In addition, Annexin V
labeling of the cells demonstrated that only 10–12% of
Pkd1/ cells were undergoing apoptosis after 48 h of serum
starvation as compared to 25–30% of Pkd1þ /- cells and a
similar percentage of MPT cells (Figure 1f). Taken together,
these data suggest that loss of Pkd1 gene expression leads
directly to expansion of the cell population in vitro due to
increased cell proliferation and decreased apoptosis.
NGAL expression inhibits cell growth
We have previously demonstrated that immortalized mouse
inner medullary collecting duct cells (mIMCD-3) express
high levels of the secreted protein NGAL. We found that
NGAL expression can regulate hepatocyte growth factor-
mediated morphogenesis in mIMCD-3 cells, and that
knockdown of NGAL resulted in a shift from tubule
formation to cyst formation.22 During the course of these
experiments, it was noted that cells in which NGAL
expression was suppressed required more frequent passaging,
suggesting that NGAL might also regulate the rate of cell
proliferation and/or apoptosis.
To determine the role of NGAL in regulating cell
proliferation, mIMCD3 cells were transfected with shRNAs
directed against NGAL or a scrambled control, and stable cells
selected as previously described.22 Of note, the knockdown
resulted in greater than 90% loss of NGAL protein expression.
Equal numbers of cells were plated and cell numbers were
determined following 2 days of culture in DMEM/F12þ 2%
FBS. Cells in which NGAL expression was suppressed exhibited
a greater increase in both total cell number (Figure 2a) and
viable cell number (Figure 2b) as compared to parental
mIMCD-3 cells or control cells expressing the scrambled
shRNA. BrdU uptake studies revealed a modest but significant
increase in proliferation by cells in which NGAL was suppressed
(Figure 2c), whereas Annexin V staining demonstrated a
marked reduction in apoptosis by these cells (Figure 2d). These
data demonstrate that high levels of NGAL expression can
suppress renal tubular cell mass expansion by decreasing
proliferation and increasing apoptosis.
NGAL can induce apoptosis of Pkd1/ cells
As the suppression of NGAL expression in mIMCD-3 cells
using shRNA resulted in the same phenotypic changes
(increased proliferation, decreased apoptosis, and increased
cyst formation) that we observed in Pkd1/ cells, we
investigated the hypothesis that loss of PC1 expression causes
a downregulation of NGAL secretion by renal tubular cells.
Examination of NGAL expression by reverse transcripta-
se–PCR and western blot analysis revealed no difference in
the levels of NGAL between Pkd1/ and PH cells (data not
shown), suggesting that PC1 expression does not directly
regulate NGAL production.
On the basis of the observation that knockdown of NGAL
expression in IMCD-3 cells resulted in an increase in cell
numbers, we examined the possibility that addition of
exogenous NGAL to Pkd1/ cells could suppress cell
proliferation. When Pkd1/ cells were cultured in the
presence of NGAL (20 mg/ml), the total cell number at the
end of 2 days was approximately 40% less than that of cells
treated with phosphate-buffered saline alone (Figure 3a).
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Figure 2 | Suppression of NGAL expression causes increased
proliferation and decreased apoptosis in IMCD cells. mIMCD-3
cells were stably transfected with two shRNAs directed against
NGAL (shRNA 1þ 2) or the scrambled control shRNA. (a) A total of
1 105 cells were plated and cultured for 48 h in the presence of
10% FBS before trypsinization and counting; n¼ 6 separate
experiments for each cell type, *Po0.04 vs cells expressing the
scrambled shRNA. (b) A total of 1 104 cells per well were plated
and cultured for 48 h in the presence of 10% FBS before
incubation with the WST-1 reagent and detection of viable cells
via determination of OD 415/655 (proliferation index); n¼ 4
independent experiments, *Po0.01 vs cells expressing the
scrambled shRNA. (c) Cells at equal density were cultured in the
presence of BrdU for 30 min before FACS analysis for BrdU
incorporation; n¼ 3 independent experiments, *Po0.03 vs cells
expressing the scrambled shRNA. (d) Cells at equal density were
serum starved for 48 h before labeling with Annexin V PE and
quantification by FACS analysis; n¼ 4 independent experiments,
*Po0.05 vs cells expressing the scrambled shRNA.
1312 Kidney International (2008) 74, 1310–1318
o r i g i n a l a r t i c l e F Wei et al.: NGAL inhibits cystogenesis
However, examination of BrdU incorporation revealed that
cell proliferation was not significantly suppressed in NGAL-
treated cells (Figure 3b). To examine the effect of NGAL on
apoptosis, Pkd1/ cells were serum starved for 2 days in the
presence or absence of 20 mg/ml NGAL. Annexin V staining
of Pkd1/ cells treated with NGAL revealed a 440%
increase in apoptosis as compared to untreated cells in both
clones tested (Figure 3c).
We have recently found that Pkd1/ cells exhibit an
increase in basal extracellular signal-regulated kinase (Erk)
activation as compared to control cells,35 and that NGAL can
inhibit hepatocyte growth factor-stimulated Erk activation.22
Erk signaling is a well-known stimulus for cell prolifera-
tion36,37 and has been shown to mediate either pro- or
antiapoptotic effects depending on the cellular context.38–40
We therefore examined the impact of NGAL on Erk
activation in Pkd1/ cells. Treatment of Pkd1/ cells with
NGAL for 24 h resulted in an 80% decrease in Erk activation
(Figure 3d, quantified in e). Thus, in Pkd1/ cells NGAL can
act to inhibit basal Erk activation and increase cell apoptosis,
leading to a decrease in cell number.
NGAL suppresses Pkd1/ cell cyst growth in vitro and in vivo
As noted, we have previously demonstrated that suppression of
NGAL expression also resulted in an increase in cyst formation
by IMCD-3 cells grown in a three-dimensional matrix.22 To
determine whether exogenous NGAL could inhibit cyst
formation by Pkd1/ cells, PN cells were suspended in a
70:30 collagen:Matrigel matrix in the presence or absence of
NGAL (20mg/ml) for 5 days. In the presence of NGAL, PN cells
were still found to form a high percentage of cysts (45.6±7.3%
cystic structures), suggesting that NGAL cannot reverse the
inherent tendency of Pkd1 null cells to form cystic rather than
tubulogenic structures. However, the cysts in the NGAL-treated
cells were found to be smaller and had less evidence of lumen
formation, suggesting that cyst growth was slowed by the
addition of NGAL (Figure 4a and b). Quantitation of relative
cyst area and volume (calculated assuming a spherical shape)
confirmed that treatment with NGAL caused a 60% reduction
in cyst growth (Figure 4c and d). Consistent with the ability of
NGAL to inhibit cell proliferation, the total number of
multicellular structures was also reduced in NGAL-treated
cells (control¼ 8.4±0.6 structures per 10 h.p.f. vs NGAL
treated¼ 3.2±0.2 (n¼ 30 wells, Po0.005)).
These results demonstrated that supplemental NGAL can
inhibit cyst growth in vitro. To determine if these effects were
reproduced in vivo, we utilized a murine model of conditional
Pkd1 knockout in the nephron. Pkd1flox/-:Ksp Cre pups35,41 were
injected intravenously on P2 and 7 with a replication
incompetent adenovirus encoding NGAL,42 or the empty
control adenovirus. The adenovirus has been shown to infect
primarily the liver, resulting in a moderate increase in
circulating and urinary levels of NGAL for 5–7 days post-
injection (Figure 5a, average serum NGAL¼ 1.6-fold greater in
NGAL-Adv-injected pups as compared to control Adv pups).
Mice were killed on P12 and the kidneys examined. Kidney
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Figure 3 | Addition of NGAL induces apoptosis in Pkd1 null cells. (a) A total of 1 104 Pkd1 null cells were plated and allowed to grow
for 48 h±NGAL (20 mg/ml) before trypsinization and counting; n¼ 6 (3 each for PN18 and PN24), *Po0.005. (b) Cells were plated
at equal density and grown for 48 h±NGAL, and labeled with BrdU for 30 min before harvest and FACS analysis; n¼ 11 (6 for PN18 and 5
for PN24). (c) Cells were plated at equal density and serum starved for 48 h before labeling with Annexin V PE and FACS analysis; n¼ 9
(4 for PN18 and 5 for PN24), *Po0.01. (d) Cells were treated for 24 h±NGAL and whole cell lysates immunoblotted for the phosphorylated
form of Erk (pErk) and for total Erk (Erk). (e) Quantitation of activated Erk normalized to total Erk for vehicle control and NGAL-treated
cells as in (d); n¼ 4, *Po0.01.
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Figure 4 | NGAL inhibits cyst growth in vitro. (a, b) Pkd1 null
cells were grown in a 70:30 collagen:Matrigel mixture for 5 days
in the (a) absence or (b) presence of added NGAL (20mg/ml).
(c, d) Quantification of cyst area and volume from cells grown as
in (a, b). Images were obtained from 10 random fields of three
separate experiments. (c) Relative cyst area (calculated as mean
pixels2 by outlining 76 cysts (36 from PN18 cells and 40 from PN24
cells) for each condition) and (d) cyst volume (calculated as pixels3
assuming a spherical shape) were determined using the Adobe
Photoshop software. *Po0.001.
Kidney International (2008) 74, 1310–1318 1313
F Wei et al.: NGAL inhibits cystogenesis o r i g i n a l a r t i c l e
weight and the ratio of kidney weight to total body weight were
significantly diminished in Pkd1flox/-:Ksp-Cre pups that received
the NGAL-expressing adenovirus compared to those that
received control adenovirus (Figure 5b and c), although they
remained substantially larger than control kidneys. Consistent
with this partial inhibition of kidney growth, TdT-mediated
dUTP nick end labeling (TUNEL) staining revealed a
significant increase in apoptosis of cyst-lining cells from the
NGAL-treated Pkd1flox/-:Ksp-Cre pups as compared to those
that received control adenovirus (Figure 5d). Hematoxylin and
eosin sections showed that the kidneys of NGAL-treated
Pkd1flox/-:Ksp-Cre pups had cysts that were typically smaller
than those in mock-treated Pkd1flox/-:Ksp-Cre littermates,
resulting in a decrease in cortical expansion in these animals
(Figure 5e). However, extensive cyst formation and growth
were present in all tubule segments in both groups as compared
to normal kidneys. Consistent with these extensive cystic
changes, blood urea nitrogen values were not significantly
different in the two groups (Figure 5f).
DISCUSSION
The present studies demonstrate that Pkd1 null cells
preferentially form cysts under conditions in which control
cells heterozygous for Pkd1, as well as other wild-type renal
cell lines, form tubules. Furthermore, Pkd1 null cells exhibit
basal rates of proliferation that are higher than control cells
and rates of apoptosis that are lower than control cells. The
two independent clones of each Pkd1 genotype cell line
should minimize the possibility that these differences are due
to the method of initial cell isolation or clonal differences
arising during cell culture, and suggest instead that selective
loss of PC1 expression directly alters cell proliferation as well
as the propensity to form cysts.
These results are in conceptual agreement with the studies
by Boletta et al.18 in which the overexpression of PC1 in
Madin–Darby canine kidney cells resulted in slower pro-
liferation and increased tubulogenesis. However, one notable
difference is that they describe decreased rates of apoptosis
with overexpression of PC1 in Madin–Darby canine kidney
cells whereas we observe decreased rates of apoptosis with
selective loss of PC1 in our cell lines. It is possible that this
difference reflects a cell-line-specific alteration in suscept-
ibility to apoptotic stimuli. Alternatively, it is possible that
there is a bell-shaped effect of PC1 expression levels on rates
of apoptosis, similar to the Pkd1 gene dose effect that is
demonstrated by the cystic kidney disease present in mice
with transgenic overexpression of PC1.43
These results also raise the question of what role apoptosis
is playing during cyst formation in polycystic kidney disease.
Although it has been reported in several nonorthologous
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on P12 for the mice treated as in (b).
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models of rodent cystic kidney disease and recently in a g-
GT-Pkd1 conditional knockout mouse44 that rates of
apoptosis are increased and that this can directly promote
cyst formation (reviewed in45), we have not observed
increased apoptosis in cyst-lining cells of either the
Pkd1flox/:Ksp-Cre mouse35 or the Pkd2WS25 mouse (unpub-
lished data). Thus, the role of apoptosis in cyst formation in
autosomal-dominant forms of polycystic kidney disease
remains unclear. Furthermore, similar to our results
demonstrating that NGAL can increase cyst-lining cell
apoptosis and slow cyst growth in the Pkd1flox/-:Ksp-Cre
mouse, Ostrom et al.46 have shown that enhanced apoptosis
can slow cyst growth in the cpk mouse.
Our data are consistent with the in vivo observations that
cyst-lining cells in humans or animals with PKD exhibit an
increased mitotic index.47,48 Multiple mechanisms for
increased proliferation in Pkd1 null cells have been proposed.
Cells lacking functional PC1 have been shown to lose flow-
dependent calcium signaling but exhibit a prolonged ligand-
activated calcium response,49 which in turn may stimulate
PKC activation and increased cell proliferation.50 Recently,
PC1 and PC2 have been suggested to regulate cell cycle
through interaction with the helix-loop-helix inhibitory
protein Id2,32 whereas Nishio et al.51 have suggested
increased proliferation of cyst cells due to downregulation
of p53. The assays described in the present study were
performed in the absence of flow and in subconfluent cells
where cilia are not expected to develop. This suggests that
PC1-dependent signals mediating the phenotypic differences
of increased proliferation and decreased apoptosis observed
in the null cells may be independent of cilial signaling
activated by flow.
The change from a tubular architecture to cystic
architecture in autosomal-dominant polycystic kidney dis-
ease occurs when a single cell in the wall of the tubule suffers
a mutation in the remaining normal copy of the Pkd gene
and the cell undergoes a change in phenotype that includes
abnormal proliferation. The net effect of the consequent
alteration leads to spherical expansion of one region of the
tubule into the surrounding interstitium, that is cyst
formation. One interpretation of this model is that
polycystins need to regulate two processes: the rate of cell
proliferation and tissue polarity of the expanding null cell
burden to account for cyst formation.52 This concept has
been supported by the mouse models of PKD in which initial
tubule development occurs normally until tubule dilatation
begins at embryonic day 15.5. Our present experiments, as
well as previous studies examining PC1 or PC2 over-
expression,18,19 demonstrate that polycystins can regulate
the inherent tendency of the cells to organize into cystic or
tubular shapes, possibly via pathways that are independent of
those regulating cell survival.
We have previously shown that suppression of expression
of the small secreted protein NGAL could shift the
phenotypic response of wild-type IMCD cells to cystogenesis
rather than tubulogenesis.22 In that study, NGAL at ng/ml
concentrations was shown to sequester hepatocyte growth
factor and prevent in vitro tubulogenesis. In the current study
we utilized mg/ml concentrations of NGAL (similar to those
used in the studies of Mori et al.53) and found that NGAL can
inhibit the growth of Pkd1 null cell-derived cysts, but not the
inherent tendency of these cells to form cysts. Thus it appears
that the anti-tubulogenic actions of NGAL on normal renal
epithelial cells are achieved at low concentrations by the
sequestration of extracellular growth factors, whereas the cyst
growth-suppressing actions require higher concentrations of
NGAL and are mediated by a different mechanism.
In addition to the extracellular sequestration of com-
pounds such as growth factors, two receptors have been
identified that can mediate NGAL uptake into cells, 24p3R
and megalin (reviewed in54). It has been demonstrated that
when NGAL is associated with siderophore or a siderophore-
like factor, cellular uptake of the NGAL–siderophore–iron
complex will act to deliver iron intracellularly and inhibit
apoptosis, whereas uptake of iron-lacking NGAL is postu-
lated to induce apoptosis via the depletion of intracellular
iron and subsequent activation of Bim1.23,54 Consistent with
these divergent phenotypes of iron-loaded and non-iron-
loaded NGAL, Mori et al.53 have shown that a NGAL–sider-
ophore–iron complex when delivered in vivo can protect mice
from ischemically induced renal injury by preventing
apoptosis of tubular cells. Thus, if taken up in sufficient
quantities by the cell, the NGAL used in our experiments
(which was purified from bacteria that do not make
siderophore) could sequester intracellular iron and induce
the apoptotic responses that inhibit cyst growth.
The results of our in vivo delivery of NGAL in Pkd1 cystic
mouse pups showed that the sustained modest increase in
circulating NGAL achieved with adenoviral delivery led to an
increase in cyst-lining cell apoptosis and a slowing of cyst
growth as demonstrated by the lesser kidney weight and
smaller cyst size histologically. We found that NGAL can
inhibit the high level of basal Erk activation seen in Pkd1 null
cells. Although this may be contributing to the proapoptotic
effect of iron-lacking NGAL, the failure of U0126 to inhibit
cyst growth in vivo35 suggests that blockade of Mek inhibition
of Erk1/2 phosphorylation alone does not explain the in vivo
effects of NGAL observed in the current studies. Despite the
decrease in the rate of cyst growth following NGAL
expression, nearly all of the tubules had undergone significant
cystic dilatation and overall renal function was not improved
in these animals. It remains to be determined whether higher
levels of NGAL might be more beneficial in these mouse
models of PKD, although the potential benefits of slower cyst
growth may well be counterbalanced by increased rates of
apoptosis in noncystic cells in the kidney and other organs.
MATERIALS AND METHODS
Cell culture
Proximal tubule cell lines null (PN18 and PN24, collectively PN
cells) and heterozygous (PH2 and PH3, collectively PH cells) for
Pkd1 were made from a single mouse carrying a conditional
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allele for Pkd1 and the conditionally immortalizing ImmortoMouse
(H-2Kb-tsA58) transgene.35 The null and heterozygous cell lines
were clonally derived from single parental Pkd1fl/- clones following
transient transfection with Cre recombinase. MPT cells are proximal
tubule cells derived from the wild-type H-2Kb-tsA58 mouse as
previously described.33 All H-2Kb-tsA58-derived cells (PN18, PN24,
PH2, PH3, and MPT) were maintained and passaged in DMEM/F12
supplemented with 10% FBS and g-interferon (5 U/ml; Sigma-
Aldrich, St. Louis, MO, USA) at 33 1C and 5% CO2. Cells were
changed to g-interferon-free medium 5 days before usage in the
described experiments and maintained at 37 1C to suppress large T
antigen expression. mIMCD-3 cells are mouse inner medullary
collecting duct cells55 and were cultured at 37 1C in DMEM/F12
supplemented with 10% FBS as described previously.22
In vitro tubulogenesis
In vitro tubulogenesis was performed as described previously.22
Briefly, cells were trypsinized and an equal number (1.5 104 per
ml) suspended in a 70:30 mixture of Collagen Type-I and Matrigel
(BD Biosciences, San Jose, CA, USA). Cultures were maintained for
a period of 1 week in the presence of DMEM/F12þ 10% FBS at
37 1C/5% CO2. In some experiments cells were cultured in the
presence or absence of NGAL (20 mg/ml). Cultures were assessed for
the presence of cyst-like or tubular structures by scoring all
structures in 10 random  20 fields/well as either cysts (spherical)
or tubules (linear structures). For each experiment, three wells were
scored for each cell type and the number and type of structures/
 20 field averaged for an n of 1. Representative structures were
photographed at  20 using a Nikon microscope with Hoffman
modulation. Images were obtained using a SpotRT digital camera
and processed using the Photoshop software.
Evaluation of cell proliferation and apoptosis
Total cell number. Cells were plated at equal amounts (1 104
for Pkd cell lines, 1 105 for IMCD, and MPT cell lines), cultured
for 2 days, and then trypsinized, resuspended and counted using a
hemocytometer to determine total cell number.
WST-1 assay. Viable cell numbers were determined using the
WST-1 assay as previously described.56 Briefly, 1 104 cells per well
were plated onto each well of a 96-well plate and cultured for 2 days.
WST-1 proliferation reagent (10ml; Roche Molecular Biochemicals,
Indianapolis, IN) was directly added to each well and the
cells incubated at 37 1C. The WST-1 reagent is a tetrazolium salt
that is cleaved by mitochondrial dehydrogenase to formazan. The
amount of formazan released directly correlates with the number of
viable cells. After 1.5 h, the colored end product was read at 415 nm
with the reference wavelength set at 655 nm. This absorbance,
corrected for absorbance of the medium, is shown as the
proliferation index.57
BrdU incorporation. Cells were plated under subconfluent
conditions and allowed to grow to near confluence in the presence
of 10% FBS. To assess the number of proliferating cells, BrdU
(10mM) was added for 30 min before washing and cell trypsinization.
BrdU-positive cells were quantified by fluorescence-activated cell
sorting (FACS) analysis using the FITC BrdU Flow kit (BD
Pharmingen, San Jose, CA, USA).
Apoptosis assay. Apoptosis was assessed by the detection of
Annexin V staining using flow cytometry. Annexin V stains the
membranes of cells expressing phosphatidylserine in the outer leaflet
of the phospholipid bilayer, an early marker of apoptosis.58 To
induce apoptosis, cells were serum starved for 2 days. Cells
were then trypsinized and incubated with PE Annexin V. Apoptotic
cell population was quantified by FACS analysis using the
Apoptosis Detection Kit (BD Pharmingen). For detection of
apoptosis in kidney sections, TUNEL staining was performed
according to the manufacturer’s instructions (Roche Molecular
Biochemicals). Kidney sections from three animals in each group
were scored in a blinded fashion for TUNEL-positive cyst-lining
cells and total cyst-lining cells (identified by 4,6-diamidino-2-
phenylindole nuclear staining) and the results expressed as
percentage of apoptotic cells. Greater than 6000 cells were scored
for each phenotype.
Western analysis of mitogen-activated protein kinase
activation. Cells were treated±NGAL for 24 h and western blots
of whole cell lysates performed as previously described.22 Activated
Erk and total Erk were detected using anti-phosphoErk and
anti-Erk antibodies, respectively (1:3000 dilution; Cell Signaling
Technologies, Danvers, MA, USA).
In vitro and in vivo experiments with NGAL
In vitro alterations of NGAL. To suppress endogenous NGAL
expression, mIMCD-3 cells were stably transfected with two shRNAs
directed against NGAL, or a scrambled control shRNA, resulting in a
490% reduction in NGAL secretion as previously described.22 For
the addition of exogenous NGAL to Pkd1 null cells, NGAL was
synthesized in BL21 bacteria in the absence of bacterial siderophore
or iron, and purified as previously described.22
In vitro expression of NGAL. Total RNA was purified from cells
by a standard Trizol preparation (Life Technologies Inc., Rockville,
MD). cDNA was synthesized from 2mg of total RNA in a 40ml
reaction, using the MMLV Superscript II enzyme and oligo-dT
primer (Life Technologies Inc.). PCR was performed with QuantiTect
SYBR Green PCR Master Mix (Qiagen, Valencia, CA, USA) using the
iCycler iQ Real-Time PCR Detection System (Bio-Rad, Hercules, CA,
USA). Each quantitative PCR reaction (25ml) was composed of
Qiagen PCR Master Mix, 0.3mM of forward and reverse primers, and
5ml of cDNA sample (reverse transcriptase product diluted 10 times).
The optimized PCR conditions for analysis consisted of 1 cycle
enzyme activation at 95 1C for 10 min, followed by 40 cycles at 95 1C
for 30 s, 60 1C for 30 s, and 72 1C for 30 s. The abundance of
individual transcript was defined by 2DCt method of quantifica-
tion59 with b-actin cDNA was used as the internal reference.
Adenoviral NGAL delivery in cystic Pkd1 mice. The NGAL
expressing adenovirus was generated using the AdTrack cytomega-
lovirus green fluorescent protein vector as previously described.42
Newborn Pkd1flox/:Ksp Cre pups35,41 were injected with 10 ml of
NGAL adenovirus or empty adenoviral vector on day 2 and day 7
and then killed at day 12. Whole body weight and kidney
weight were measured, and kidneys were preserved in formaldehyde
for sectioning and hematoxylin and eosin staining. Blood urea
nitrogen values were performed by the Mouse Metabolic Phenotyp-
ing Center at Yale University using the COBAS Integra system
(Roche).
Statistical analysis
A two-tailed Student’s t-test was used to analyze and compare data
within the groups. Data are presented as mean±s.e.m.
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